Accèdez sans limite aux 15 000 actualités du site et recevez gratuitement chaque semaine, la Newsletter Santé log avec les actus Santé à ne pas manquer !

ExpertCare featured in Innovate UK Research Project ...

The Tecan Group (SIX Swiss Exchange: TECN) today announced a planned CEO transition, marking a new chapter in the company’s successful growth story. After nearly 12 years with Tecan, including 6 ½ ...

Effective from 1 October 2025, CMS and commercial health insurers will recognise the HCPCS Level II code A9616 assigned for reimbursement of Gozellix. The assignment of the code is a significant ...

About the Setrusumab Phase 3 Program Ultragenyx is developing setrusumab in pediatric and young adult patients across OI sub-types I, III and IV with two late-stage studies: the pivotal Phase 2/3 ...

The Inducement Grants have been granted pursuant to the Company’s 2023 Inducement Plan (the “Plan”). The Inducement Grants were granted as an inducement material to these individuals entering into ...

ZUG, Switzerland, July 09, 2025 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting and settlement of RSUs previously granted to directors of the Company.

Ladenburg Thalmann & Co, Inc. is acting as the exclusive placement agent for the offering.

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases, ...

ALLENTOWN, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- HNL Lab Medicine has been named a recipient of the 2025 Empowering Women Award by Lehigh Valley Business and Central Penn Business Journal, in ...

OXFORD, United Kingdom and MADISON, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, has been announced as the winner of the prestigious 2025 MacRobert ...

TORONTO, July 09, 2025 (GLOBE NEWSWIRE) -- Today, the Healthcare of Ontario Pension Plan (HOOPP) is pleased to announce changes to its executive leadership team.